NCT02936141 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Dennis DL, Buckner JC, Lipton FR, Levine IS
A decade of research and services for homeless mentally ill persons. Where do we stand? Am Psychol. 1991 Nov;46(11):1129-38. Review.
Folsom DP, Hawthorne W, Lindamer L, Gilmer T, Bailey A, Golshan S, Garcia P, Unützer J, Hough R, Jeste DV
Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large
Patel V, Simbine AP, Soares IC, Weiss HA, Wheeler E
Prevalence of severe mental and neurological disorders in Mozambique: a population-based survey. Lancet. 2007 Sep 22;370(9592):1055-60.
Patra S, Anand K
Homelessness: a hidden public health problem. Indian J Public Health. 2008 Jul-Sep;52(3):164-70.
Scott J
Homelessness and mental illness. Br J Psychiatry. 1993 Mar;162:314-24. Review.
Sullivan G, Burnam A, Koegel P
Pathways to homelessness among the mentally ill. Soc Psychiatry Psychiatr Epidemiol. 2000 Oct;35(10):444-50.

Psychosocial Intervention Targeting Homeless With Mental Disorders in the City of Maputo and Matola: a Study Protocol

Clinical trial NCT02936141 - References